|
Novel Glyco-tests to Predict Chemoresistance
|
3R43CA213766-01A1S1
|
$50,000
|
$50,000
|
RAZI, NAHID
|
ACCUDAVA, INC.
|
|
Novel Glyco-tests to Predict Chemoresistance
|
3R43CA213766-01A1S2
|
$149,785
|
$149,785
|
RAZI, NAHID
|
ACCUDAVA, INC.
|
|
Minimally Invasive High Intensity Ultrasound Treatment of Uterine Fibroids
|
5R44CA121740-03
|
$640,042
|
|
BURDETTE, EVERETTE
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Persistent HPV Infection in Women at Risk for Cervix Cancer
|
5U01CA078527-17
|
|
|
BURK, ROBERT
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Rac1 regulates protrusion and invasion of breast cancers in 3D
|
5R21CA181838-02
|
|
|
HODGSON, LOUIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Deciphering the Tissue Specificity of MEN1 Related Tumorigenesis
|
5R01CA170911-04
|
|
|
LIBUTTI, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Genomics and Predictive Modeling of Prostate Cancer Heath Disparity
|
6U01CA158431-05
|
$315,393
|
|
OSTRER, HARRY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-45S1
|
$3,646,138
|
$36,461
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Inhibition of Senescence to Increase Cancer Cell Death: A New Paradigm
|
5R01CA077263-19
|
$417,500
|
$137,775
|
MCDAID, HAYLEY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Nemours NCI Community Oncology Research Program (NCORP)
|
5UG1CA189958-02
|
$992,500
|
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
PNNL Proteome Characterization Center
|
5U24CA210955-03
|
$1,063,923
|
$351,095
|
LIU, TAO
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
Bay Area Tumor Institute NCORP
|
5UG1CA189817-02
|
$667,500
|
|
GREIF, JON
|
BAY AREA TUMOR INSTITUTE
|
|
Advanced Glycation End-Products and Risk of Pancreatic Cancer
|
5R01CA172880-03
|
$498,656
|
|
JIAO, LI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Novel therapeutics for targeting checkpoint dysfunction in cancer
|
5R01CA203824-02
|
$362,569
|
$90,642
|
LIN, WEEI-CHIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Functional characterization of brain-colonizing breast cancer CTC subsets
|
1R01CA193213-01
|
$376,502
|
|
MARCHETTI, DARIO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Metabolic Regulation in Leukemia-Initatiating Cells
|
1R01CA193235-01
|
$461,462
|
|
NAKADA, DAISUKE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S1
|
$118,875
|
$2,378
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S2
|
$249,997
|
$5,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
$2,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
$64,062
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis
|
5R01CA181808-05
|
$336,565
|
$336,565
|
RICHARDS, JOANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Gut L-Histidine Metabolism and Histamine Signaling in Colonic Neoplasia
|
5U01CA170930-03
|
$584,586
|
|
VERSALOVIC, JAMES
|
BAYLOR COLLEGE OF MEDICINE
|
|
CHARACTERIZATION OF RECURRENT ADJACENT GENE TRANSLOCATIONS IN BREAST CANCER
|
5R01CA183976-02
|
$326,710
|
|
WANG, XIAOSONG
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Function of Cdc14B in DNA Damage Repair and Tumorigenesis
|
5R01CA116097-10
|
$269,732
|
|
ZHANG, PUMIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC
|
5U24CA210954-03
|
$973,045
|
$330,835
|
ZHANG, BING
|
BAYLOR COLLEGE OF MEDICINE
|
|
Discovery and Characterization of Mutations in Breast and Ovarian Cancers
|
5R50CA211280-03
|
$215,047
|
$107,524
|
ADAMSON, AARON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy
|
3R01CA197359-04S1
|
$68,577
|
$68,577
|
BERLIN, JACOB
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy
|
5R01CA197359-04
|
$388,875
|
$388,875
|
BERLIN, JACOB
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Combating Subclonal Evolution of Resistant Cancer Phenotypes
|
3U54CA209978-03S1
|
$125,000
|
$43,750
|
BILD, ANDREA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Combating Subclonal Evolution of Resistant Cancer Phenotypes
|
5U54CA209978-03
|
$2,154,776
|
$754,172
|
BILD, ANDREA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
2P30CA033572-35
|
$2,543,187
|
$76,296
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S3
|
$865,000
|
$25,950
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-35S1
|
$43,750
|
$1,313
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Molecular Mechanisms of BRCA1-Dependent DNA Damage Response and Tumorogenesis
|
5R01CA132755-11
|
$382,500
|
$126,225
|
YU, XIAOCHUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Functional analysis of BRCA1 in DNA damage response and tumor suppression
|
5R01CA187209-05
|
$352,750
|
$176,375
|
YU, XIAOCHUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Computational pathology to predict breast cancer risk in benign breast disease
|
1R21CA187642-01A1
|
$247,844
|
|
BECK, ANDREW
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Elucidating a Novel Akt Activation Mechanism for Targeted Prostate Cancer Therapy
|
5K99CA181342-02
|
$169,668
|
|
LIU, PENGDA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
BRAFV600E and VEGFR2 synergize to trigger papillary thyroid cancer progression
|
5R01CA181183-02
|
$361,050
|
|
NUCERA, CARMELO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Analysis of BRCA1 Recombination Functions
|
5R01CA095175-14
|
$328,700
|
$164,350
|
SCULLY, RALPH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Down Syndrome Candidate Region 1 isoform 1L in tumor growth and metastasis
|
1R03CA194795-01
|
$87,000
|
|
ZENG, HUIYAN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Parallel and high throughput isolation of cancer cell derived extracellular vesicles
|
1R43CA232848-01
|
$239,138
|
$119,569
|
MULLER, ROLF
|
BIOFLUIDICA, INC
|
|
Cancer Deep Phenotype Extraction from Electronic Medical Records
|
5U24CA184407-06
|
$993,015
|
$327,695
|
SAVOVA, GUERGANA
|
BOSTON CHILDREN'S HOSPITAL
|
|
Feasibility of Molecular Cytology for the Management of Barrett's Esophagus
|
1R21CA187753-01A1
|
$214,371
|
|
GODFREY, TONY
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5U01CA164974-08
|
$3,131,894
|
$313,189
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Enzyme-instructed self-assembly for molecular anticancer nanomedicines
|
5R01CA142746-09
|
$368,145
|
$368,145
|
XU, BING
|
BRANDEIS UNIVERSITY
|
|
Targeting Endoplasmic Reticulum Stress Response for Cancer Therapy
|
5R01CA152312-05
|
$355,348
|
|
AKTAS, BERTAL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Validation of Prognostic and Diagnostic Molecular Tests in Mesothelioma
|
5R01CA120528-10
|
$345,927
|
|
BUENO, RAPHAEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Advanced Training in Surgical Oncology
|
5T32CA009535-28
|
$225,135
|
|
BUENO, RAPHAEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Investigating the cytomegalovirus link to glioblastoma using a novel mouse model
|
1R01CA195532-01
|
$396,329
|
|
CHIOCCA, E.
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mucins and immune cell interactions in ovarian cancer pathogenesis & progression
|
5R35CA197605-03
|
$966,086
|
$966,086
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Ovarian Cancer for this search: $127,398,144
|